Presentation is loading. Please wait.

Presentation is loading. Please wait.

Amy M. Tetrault, B. S. , M. S. , Susan M. Richman, M. D

Similar presentations


Presentation on theme: "Amy M. Tetrault, B. S. , M. S. , Susan M. Richman, M. D"— Presentation transcript:

1 Decreased endometrial HOXA10 expression associated with use of the copper intrauterine device 
Amy M. Tetrault, B.S., M.S., Susan M. Richman, M.D., Xiaolan Fei, M.D., Hugh S. Taylor, M.D.  Fertility and Sterility  Volume 92, Issue 6, Pages (December 2009) DOI: /j.fertnstert Copyright © 2009 American Society for Reproductive Medicine Terms and Conditions

2 Figure 1 Endometrial HOXA10 expression using immunohistochemical analysis. Endometrial HOXA10 expression was predominantly localized in the stroma and statistically significantly decreased in (A) patients using Paraguard T380A when compared with (B) nonusers of an intrauterine device (IUD). Representative photomicrographs illustrate immunohistochemistry results performed with a HOXA10 polyclonal antibody (magnification ×40). Fertility and Sterility  , DOI: ( /j.fertnstert ) Copyright © 2009 American Society for Reproductive Medicine Terms and Conditions

3 Figure 2 The effect of copper intrauterine device (IUD) usage on endometrial cell HOXA10 expression. The mean H scores for endometrial stromal HOXA10 expression for Paraguard T380A users were statistically significantly decreased in comparison with nonusers (∗P<.001). Fertility and Sterility  , DOI: ( /j.fertnstert ) Copyright © 2009 American Society for Reproductive Medicine Terms and Conditions


Download ppt "Amy M. Tetrault, B. S. , M. S. , Susan M. Richman, M. D"

Similar presentations


Ads by Google